The market seems to be waiting for confirmation about these products technology in order to push the price further.
An announcement regarding SCS is probable soon. Once SCS proves merit most likely the price will surge again. Yet another finance announcement is also possible.
Personally $35 per share within the next two years is my expectation.
Recent MBOT News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2024 02:02:52 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/06/2024 02:02:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2024 02:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 12:30:24 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:38:15 PM
- Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 • GlobeNewswire Inc. • 10/15/2024 12:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:10:21 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:07:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:33:51 PM
- Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up • GlobeNewswire Inc. • 09/30/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:30:27 PM
- Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System • GlobeNewswire Inc. • 09/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 05:00:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:36:31 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:33:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 12:30:38 PM
- Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:34:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:32:11 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 05:15:42 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:46 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM